Literature DB >> 21963448

A survey of expectations and understanding of palliative radiotherapy from patients with advanced cancer.

G Mitera1, L Zhang, A Sahgal, E Barnes, M Tsao, C Danjoux, L Holden, E Chow.   

Abstract

AIMS: To assess patients' understanding of their illness and expectations of palliative radiotherapy for symptomatic metastases before and after consultation and to explore the relationship between response and demographics/Edmonton Symptom Assessment Scale (ESAS) scores.
MATERIALS AND METHODS: In total, 100 participants completed a survey before and after consultation from March to October 2009. Descriptive statistics and statistical analyses were conducted to compare responses and to determine any relationship between responses and demographics or ESAS variables.
RESULTS: Up to 25% believed their cancer was curable; there was no change in belief that radiotherapy would cure their cancer (17% before and 15% after) or prolong their life (40% before and 45% after). There were significant differences in radiotherapy expectation for symptom relief (P=0.0094) and for patients who did not know the role of radiotherapy (P=0.0025). Patient anxiety was reduced after consultation on questions about radiotherapy (P<0.001), concerns on effectiveness (P<0.0001) and side-effects of treatment (P<0.0001); 96, 24 and 46% said after consultation that they were satisfied with information from the team, better understood their diagnosis of cancer and the role of radiotherapy, respectively.
CONCLUSION: A significant proportion of patients with advanced disease believe their cancer is curable, expect that radiotherapy will cure their cancer and prolong their life despite understanding the intent of radiotherapy is for symptom relief. After consultation, patients say they have a better understanding of their cancer and feel more confident about treatment. More work is needed to improve patients' understanding of their illness and expectations of the role of palliative radiotherapy.
Copyright © 2011 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21963448     DOI: 10.1016/j.clon.2011.09.001

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  7 in total

1.  Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.

Authors:  Srinivas Raman; Keyue Ding; Edward Chow; Ralph M Meyer; Yvette M van der Linden; Daniel Roos; William F Hartsell; Peter Hoskin; Jackson S Y Wu; Abdenour Nabid; Rick Haas; Ruud Wiggenraad; Scott Babington; William F Demas; Carolyn F Wilson; Rebecca K S Wong; Liting Zhu; Michael Brundage
Journal:  Qual Life Res       Date:  2017-11-29       Impact factor: 4.147

2.  What are cancer centers advertising to the public?: a content analysis.

Authors:  Laura B Vater; Julie M Donohue; Robert Arnold; Douglas B White; Edward Chu; Yael Schenker
Journal:  Ann Intern Med       Date:  2014-06-17       Impact factor: 25.391

3.  A qualitative study of patient and clinician attitudes regarding surveillance after a resection of pancreatic and peri-ampullary cancer.

Authors:  Raymond G Deobald; Eva S W Cheng; Yoo-Joung Ko; Frances C Wright; Paul J Karanicolas
Journal:  HPB (Oxford)       Date:  2014-12-24       Impact factor: 3.647

4.  Self-Deception in Terminal Patients: Belief System at Stake.

Authors:  Luis E Echarte; Javier Bernacer; Denis Larrivee; J V Oron; Miguel Grijalba-Uche
Journal:  Front Psychol       Date:  2016-02-09

5.  Pre-treatment expectations of patients with spinal metastases: what do we know and what can we learn from other disciplines? A systematic review of qualitative studies.

Authors:  R Gal; D Oostinga; H Wessels; J J Verlaan; R Charest-Morin; C G Fisher; H M Verkooijen; A L Versteeg
Journal:  BMC Cancer       Date:  2020-12-09       Impact factor: 4.430

6.  Continuous controversy about radiation oncologists' choice of treatment regimens for bone metastases: should we blame doctors, cancer-related features, or design of previous clinical studies?

Authors:  Carsten Nieder; Adam Pawinski; Astrid Dalhaug
Journal:  Radiat Oncol       Date:  2013-04-10       Impact factor: 3.481

7.  Individual difficulties and resources - a qualitative analysis in patients with advanced lung cancer and their relatives.

Authors:  Anika Sparla; Sebastian Flach-Vorgang; Matthias Villalobos; Katja Krug; Martina Kamradt; Kadiatou Coulibaly; Joachim Szecsenyi; Michael Thomas; Sinikka Gusset-Bährer; Dominik Ose
Journal:  Patient Prefer Adherence       Date:  2016-10-03       Impact factor: 2.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.